Pharmaceutical Executive
An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Donald Han
Advertisement
Articles by Donald Han
Advertisement
Latest Updated Articles
Improving Management of Gene and Cell TherapiesSeptember 10th 2018
Advertisement
Advertisement
Trending on PharmExec
1
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ
2
How Basket-Trials are Reshaping Drug Development Timelines
3
Accelerating Speed to Patient: A Conversation With Eli Lilly’s Sarah O’Keeffe
4
The New Capital of Care in Rare Disease
5